How many institutions own IPHA stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IPHA shares is 10, representing 0.17% of the company's common stock.

Who are the major shareholders selling Innate Pharma S.A. stock?

OPTIVER HOLDING B.V., in the last quarter, reduced its stake in IPHA by -100% restricting it's holding to 0 shares of worth nearly -. CITADEL ADVISORS LLC also lessened -100% of the IPHA shares from its portfolio, reducing its holding to 0 shares of worth -. PRINCIPAL SECURITIES, INC. also shunned IPHA shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying IPHA stock?

As per its latest 13F filing, SAGEVIEW ADVISORY GROUP, LLC increased its stake in IPHA by 100% in the last quarter. The institutional holder raised its holding to 1 shares having worth more than $2.00. RHUMBLINE ADVISERS also added 1,007.23% more shares of IPHA to its portfolio, raising its holding to 5.2 thousand shares of worth $9.11K. MILLENNIUM MANAGEMENT LLC also increased its IPHA shares holding by 100% which brought its holding to 20.31 thousand shares worth $35.54K.

IPHA's major insiders: who are they?

The insider with the most stakes in IPHA is N/A , N/A at the company. Additionally, IPHA stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell IPHA stock?

Company executives, directors, and other insiders own N/A percent of Innate Pharma S.A.'s stock. Within the last six months, there have been 0 transaction(s) in which IPHA insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased IPHA stock?

There have been 0 transaction(s) during the past 6-months in which Innate Pharma S.A. insiders have bought stock, totalling 0 shares

How much of IPHA does insiders own?

Around 0 Innate Pharma S.A. shares are held by insiders, which represents about N/A of IPHA stock.

Who is the insider with the largest stake?

IPHA N/A, N/A holds the largest portfolio of the company's shares. IPHA shares owned by N/A total nearly -.

Which institution holds the most shares in IPHA?

OPTIVER HOLDING B.V. is the largest institutional owner in IPHA which holds 0 shares worth - or 0% of the total IPHA shares outstanding followed by CITADEL ADVISORS LLC with ownership of 0 shares representing 0% of the IPHA ownership. PRINCIPAL SECURITIES, INC. is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Innate Pharma S.A. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IPHA is concerned, it is a stock which is not optionable.

Is there a short position on IPHA's shares?

Number of IPHA shares short is 70.23K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding IPHA shares are there?

As of today, 92.17M shares of IPHA are outstanding.

Is there many float in IPHA stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IPHA has 59.22M shares in float.

IPHA short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IPHA is 5.61.

Innate Pharma SA (IPHA) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.08

Short Percent Of Float0.09

Shares Outstanding92.17M

Shares Float59.22M

Shares Short70.23K

Short Ratio5.61

0.09%

Short % of Float

0.08%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

N/A Percentage of Shares held by All Insiders

0.17% Percentage of Shares held by All Institutions

0.17% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 0.17% of IPHA shares are held by financial institutions. OPTIVER HOLDING B.V. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Innate Pharma S.A. is owned by the company. CITADEL ADVISORS LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2025	OPTIVER HOLDING B.V.	0%	0	-	-101	-100.00%
Dec 31, 2025	CITADEL ADVISORS LLC	0%	0	-	-20.04K	-100.00%
Dec 31, 2025	PRINCIPAL SECURITIES, INC.	0%	0	-	-45	-100.00%
Dec 31, 2025	SAGEVIEW ADVISORY GROUP, LLC	0%	1	2	1	+100.00%
Dec 31, 2025	BARCLAYS PLC	0%	1	2	-306	-99.67%
Dec 31, 2025	FARTHER FINANCE ADVISORS, LLC	0%	10	18	0	0
Dec 31, 2025	UBS GROUP AG	0%	947	1.66K	-3.85K	-80.26%
Dec 31, 2025	GAMMA INVESTING LLC	0%	1.07K	1.88K	-1.21K	-52.96%
Dec 31, 2025	RHUMBLINE ADVISERS	0.01%	5.2K	9.11K	4.73K	+1,007.23%
Dec 31, 2025	MILLENNIUM MANAGEMENT LLC	0.02%	20.31K	35.54K	20.31K	+100.00%
Dec 31, 2025	OLD MISSION CAPITAL LLC	0.03%	28.43K	49.75K	28.43K	+100.00%
Dec 31, 2025	MORGAN STANLEY	0.05%	46.39K	81.19K	-7.17K	-13.39%
Dec 31, 2025	LION POINT CAPITAL, LP	0.1%	81.15K	142.01K	81.15K	+100.00%
Dec 31, 2025	JANE STREET GROUP, LLC	0.11%	92.75K	162.32K	92.75K	+100.00%
Sep 30, 2025	OPTIVER HOLDING B.V.	0%	101	197	0	0
Sep 30, 2025	FARTHER FINANCE ADVISORS, LLC	0%	10	19	10	+100.00%
Sep 30, 2025	MILLENNIUM MANAGEMENT LLC	0%	0	-	-11.66K	-100.00%
Sep 30, 2025	GAMMA INVESTING LLC	0%	2.28K	4.4K	-1.18K	-34.00%
Sep 30, 2025	CITADEL ADVISORS LLC	0.02%	20.04K	39.08K	-6.58K	-24.70%
Sep 30, 2025	BARCLAYS PLC	0%	307	593	0	0
Sep 30, 2025	UBS GROUP AG	0.01%	4.8K	9.26K	-1.16K	-19.47%
Sep 30, 2025	RHUMBLINE ADVISERS	0%	470	916	0	0
Sep 30, 2025	MORGAN STANLEY	0.06%	53.56K	103.38K	2.34K	+4.57%
Sep 30, 2025	PRINCIPAL SECURITIES, INC.	0%	45	87	0	0
Jun 30, 2025	UBS GROUP AG	0.01%	5.96K	10.81K	-3.04K	-33.82%
Jun 30, 2025	GAMMA INVESTING LLC	0%	3.46K	6.27K	1.22K	+54.77%
Jun 30, 2025	OPTIVER HOLDING B.V.	0%	101	177	0	0
Jun 30, 2025	MORGAN STANLEY	0.06%	51.22K	92.97M	7.7K	+17.69%
Jun 30, 2025	PRINCIPAL SECURITIES, INC.	0%	45	82	45	+100.00%
Jun 30, 2025	EXCHANGE TRADED CONCEPTS, LLC	0%	0	-	-62.75K	-100.00%
Jun 30, 2025	CITADEL ADVISORS LLC	0.03%	26.62K	46.58M	2.35K	+9.68%
Jun 30, 2025	MILLENNIUM MANAGEMENT LLC	0.01%	11.66K	20.41K	-3.67K	-23.91%
Jun 30, 2025	RHUMBLINE ADVISERS	0%	470	822	-205	-30.37%
Jun 30, 2025	BARCLAYS PLC	0%	307	1K	0	0
Jun 30, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0%	0	-	-3	-100.00%
Mar 31, 2025	CITADEL ADVISORS LLC	0.03%	24.27K	43.2K	12.41K	+104.73%
Mar 31, 2025	MORGAN STANLEY	0.05%	43.52K	77.47K	0	0
Mar 31, 2025	EXCHANGE TRADED CONCEPTS, LLC	0.08%	62.75K	111.7K	-14.6K	-18.87%
Mar 31, 2025	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	0	-	-200	-100.00%
Mar 31, 2025	GAMMA INVESTING LLC	0%	2.23K	3.98K	2.23K	+100.00%
Mar 31, 2025	TOWER RESEARCH CAPITAL LLC (TRC)	0%	3	5	3	+100.00%
Mar 31, 2025	MILLENNIUM MANAGEMENT LLC	0.02%	15.33K	27.28K	15.33K	+100.00%
Mar 31, 2025	UBS GROUP AG	0.01%	9K	16.02K	5.49K	+156.44%
Mar 31, 2025	BARCLAYS PLC	0%	307	1K	0	0
Mar 31, 2025	NATIONAL BANK OF CANADA /FI/	0%	0	-	-450	-100.00%
Mar 31, 2025	OPTIVER HOLDING B.V.	0%	101	180	0	0
Mar 31, 2025	RHUMBLINE ADVISERS	0%	675	1.2K	0	0
Mar 31, 2024	OPTIVER HOLDING B.V.	0.09%	70.56K	203.22K	47.86K	+210.79%
Mar 31, 2024	EXCHANGE TRADED CONCEPTS, LLC	0.14%	113.07K	325.64K	66.18K	+141.15%
Mar 31, 2024	MORGAN STANLEY	0.05%	44.12K	127.08K	-2.23K	-4.81%
Mar 31, 2024	RHUMBLINE ADVISERS	0%	205	590	0	0
Mar 31, 2024	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	200	576	0	0
Mar 31, 2024	BARCLAYS PLC	0%	412	1K	0	0
Mar 31, 2024	MILLENNIUM MANAGEMENT LLC	0.01%	10.58K	30.47K	-1.42K	-11.86%
Mar 31, 2024	JANE STREET GROUP, LLC	0.02%	14.55K	41.92K	14.55K	+100.00%
Mar 31, 2024	UBS GROUP AG	0%	210	604	64	+43.84%
Dec 31, 2023	BARCLAYS PLC	0%	412	1K	0	0
Dec 31, 2023	EXCHANGE TRADED CONCEPTS, LLC	0.06%	46.89K	131.29K	11.89K	+33.97%
Dec 31, 2023	MILLENNIUM MANAGEMENT LLC	0.02%	12K	33.61K	-34.97K	-74.45%
Dec 31, 2023	OPTIVER HOLDING B.V.	0.03%	22.71K	63.57K	-167.51K	-88.06%
Dec 31, 2023	MORGAN STANLEY	0.06%	46.35K	129.79K	1.4K	+3.11%
Dec 31, 2023	UBS GROUP AG	0%	146	409	0	0
Dec 31, 2023	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	200	560	-300	-60.00%
Dec 31, 2023	RHUMBLINE ADVISERS	0%	205	574	0	0

IPHA Stock Ownership Breakdown

Innate Pharma SA

Stock Outstanding Shares

Market Insider

Institutional Ownership

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Frequently Asked Questions